Back
Enanta Pharmaceuticals Vs. Cassava Sciences Industry Stock Comparison
Sell
28
ENTA
Enanta Pharmaceuticals
Last Price:
9.38
Seasonality Move:
15.66%
Buy
63
SAVA
Cassava Sciences
Last Price:
26.63
Seasonality Move:
47.33%
Sell
28
Enanta Pharmaceuticals (ENTA)
is a Sell
Is Enanta Pharmaceuticals a Buy, Sell or Hold?
- The current Enanta Pharmaceuticals [ENTA] share price is $9.31. The Score for ENTA is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- ENTA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
63
Cassava Sciences (SAVA)
is a Buy
Is Cassava Sciences a Buy, Sell or Hold?
- The current Cassava Sciences [SAVA] share price is $32.18. The Score for SAVA is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- SAVA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ENTA Stock Price Chart
What is Enanta Pharmaceuticals's stock price today?
-
The Enanta Pharmaceuticals share price today is $9.31
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ENTA is experiencing buying pressure, which is a positive indicator for future bullish movement.
SAVA Stock Price Chart
What is Cassava Sciences's stock price today?
-
The Cassava Sciences share price today is $32.18
The current trend is moderately bullish and SAVA is experiencing buying pressure, which is a positive indicator for future bullish movement.
ENTA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.6 | Sell |
| Relative Strength Index (14 RSI): | 28.87 | Sell |
| Chaikin Money Flow: | 165985 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.99 - 12.17) | Sell |
| Bollinger Bands (100): | (10.7 - 14) | Sell |
SAVA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.36 | Buy |
| Relative Strength Index (14 RSI): | 64.8 | Buy |
| Chaikin Money Flow: | 2523870 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.39 - 28.53) | Buy |
| Bollinger Bands (100): | (17.94 - 31.2) | Buy |
ENTA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.77 | Sell |
| 20-day SMA: | 10.69 | Sell |
| 50-day SMA: | 11.14 | Sell |
| 200-day SMA: | 13.04 | Sell |
| 8-day EMA: | 9.75 | Sell |
| 20-day EMA: | 10.45 | Sell |
| 50-day EMA: | 11.18 | Sell |
| 200-day EMA: | 13.13 | Sell |
SAVA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.35 | Buy |
| 20-day SMA: | 26.62 | Buy |
| 50-day SMA: | 27.56 | Buy |
| 200-day SMA: | 22.93 | Buy |
| 8-day EMA: | 27.96 | Buy |
| 20-day EMA: | 27.22 | Buy |
| 50-day EMA: | 26.84 | Buy |
| 200-day EMA: | 24.22 | Buy |
Enanta Pharmaceuticals Earnings Growth & ENTA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.01 per share, and an increase next year of $0.23 per share.
Cassava Sciences Earnings Growth & SAVA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.98 per share, and an increase next year of $0.59 per share.
Enanta Pharmaceuticals Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cassava Sciences Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||